Potential delays in clinical trials may result in extended timelines for new drug approvals, and a sudden reduction in ...
Universities and colleges built budgets around federal largess. The Trump administration is forcing them to take a fiscal haircut on indirect costs.
National Institutes of Health slashed overhead costs allowed under its grants to match private foundations, but the two don't ...
The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.